Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Höflich

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|November 14, 2002
[Immunomodulation in sepsis]C Höflich, H D Volk
Deutsche Medizinische Wochenschrift (1946)|October 30, 2008
[Immune monitoring in SIRS and sepsis based on the PIRO model]C Meisel, C Höflich, H-D Volk
Current Medical Research and Opinion|January 1, 1996
Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray--non-sedating in childrenW Lassig, W Wober, C Höflich, et al.
Zentralblatt Fur Chirurgie|October 13, 2005
[Impact of pneumoperitoneum on expression of E-cadherin, CD44v6 and CD54 (ICAM-1) on HT-29 colon-carcinoma cells]J Ordemann, C Höflich, C Braumann, et al.
Die Pharmazie|August 1, 1996
[Studies on the bioavailability of beta-aescin following oral administration of various dosage forms. Commentary on the work of Kunz et al. as well as Schrader et al., published in this journal]M Dittgen, H Zimmermann, W Wober, et al.
International Immunology|January 14, 1999
CD45RA(bright)/CD11a(bright) CD8+ T cells: effector T cellsC Höflich, W D Döcke, A Busch, et al.
Clinical and Experimental Immunology|February 1, 2008
Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatmentN Ahrens, C Höflich, S Bombard, et al.
Ernst Schering Foundation Symposium Proceedings|September 11, 2007
Immunomodulatory therapies: challenges of individualized therapy strategiesH D Volk, B Sawitzki, F Kern, et al.
Immunology Letters|June 1, 1997
Selective in vivo deletion of alloactivated TH1 cells by OKT3 monoclonal antibody in acute rejectionP Reinke, H Schwinzer, C Höflich, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 23, 2017
First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-IH Kletzl, A Guenther, A Höflich, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|November 14, 2002
[Immunomodulation in sepsis]C Höflich, H D Volk
Deutsche Medizinische Wochenschrift (1946)|October 30, 2008
[Immune monitoring in SIRS and sepsis based on the PIRO model]C Meisel, C Höflich, H-D Volk
Current Medical Research and Opinion|January 1, 1996
Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray--non-sedating in childrenW Lassig, W Wober, C Höflich, et al.
Zentralblatt Fur Chirurgie|October 13, 2005
[Impact of pneumoperitoneum on expression of E-cadherin, CD44v6 and CD54 (ICAM-1) on HT-29 colon-carcinoma cells]J Ordemann, C Höflich, C Braumann, et al.
Die Pharmazie|August 1, 1996
[Studies on the bioavailability of beta-aescin following oral administration of various dosage forms. Commentary on the work of Kunz et al. as well as Schrader et al., published in this journal]M Dittgen, H Zimmermann, W Wober, et al.
International Immunology|January 14, 1999
CD45RA(bright)/CD11a(bright) CD8+ T cells: effector T cellsC Höflich, W D Döcke, A Busch, et al.
Clinical and Experimental Immunology|February 1, 2008
Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatmentN Ahrens, C Höflich, S Bombard, et al.
Ernst Schering Foundation Symposium Proceedings|September 11, 2007
Immunomodulatory therapies: challenges of individualized therapy strategiesH D Volk, B Sawitzki, F Kern, et al.
Immunology Letters|June 1, 1997
Selective in vivo deletion of alloactivated TH1 cells by OKT3 monoclonal antibody in acute rejectionP Reinke, H Schwinzer, C Höflich, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 23, 2017
First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-IH Kletzl, A Guenther, A Höflich, et al.
Pageof 2